RU58841 – Powder, 5 grams
RU58841 – Powder, 5 grams
Currently unavailable
NovaMeds
Noopept (Omberacetam, GVS-111) powder (10 g) provides a bulk format for laboratory applications requiring solution preparation, custom formulation, or extended-duration research protocols.
Presentation: Noopept (Omberacetam) – Powder, 10 grams.
Illustrative packaging generated with AI.
Not for human or veterinary use.
Noopept (Omberacetam, GVS-111) powder (10 g) provides a bulk format for laboratory applications requiring solution preparation, custom formulation, or extended-duration research protocols. As a prodrug of cycloprolylglycine (cPG), it modulates AMPA receptors, inhibits NMDA-mediated excitotoxicity, and upregulates BDNF/NGF in preclinical neuronal models.
The powder format enables precise dose preparation and concentration-response experiments across a wider range than fixed-unit capsules allow.
| Chemical Formula | C17H22N2O4 |
|---|---|
| Synonyms | GVS-111, Omberacetam, N-Phenylacetyl-L-prolylglycine ethyl ester |
| Molar Mass | 318.37 g/mol |
| CAS Number | 157115-85-0 |
| PubChem CID | 180496 |
| Total Compound Content | 10 g powder |
| Shelf Life | 36 months |
Noopept powder (10 g) provides the same dipeptide-derived compound as the capsule format in bulk unencapsulated form. As a prodrug of cycloprolylglycine (cPG), Noopept undergoes metabolic conversion to a cyclic peptide metabolite that has been investigated in studies of glutamatergic signaling, receptor-associated regulatory pathways, and molecular communication networks. The bulk powder format is particularly useful for formulation development, solution preparation, concentration-response investigations, analytical chemistry applications, and comparative studies requiring precise control over experimental parameters. Experimental research has examined Noopept in relation to AMPA- and NMDA-associated signaling systems, prodrug conversion mechanisms, and structure-function relationships involving small molecule–peptide pharmacology. Independently third-party HPLC-tested; COA available per batch.
Noopept exhibits limited aqueous solubility and greater solubility in a range of polar organic solvents. These physicochemical properties make it useful for studies involving solution preparation, analytical chemistry workflows, formulation development, and concentration-dependent experimental investigations.
Researchers frequently examine its solubility behavior when evaluating compound stability, solvent compatibility, and formulation characteristics across different experimental systems.
The powder format provides greater flexibility for formulation development, analytical investigations, concentration-response studies, and experimental designs requiring precise control over compound quantities and preparation parameters. It is particularly useful for research involving solution preparation, comparative formulation analysis, physicochemical characterization, and studies examining the influence of formulation variables on compound behavior.
Noopept powder should be stored in a sealed container protected from moisture, light, and excessive heat to preserve compound integrity and stability. Appropriate storage conditions help minimize degradation processes and maintain the physicochemical properties of the material over time.
These considerations are particularly important in research settings where compound consistency, stability assessment, and reproducibility are critical experimental factors.